Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies : HF-ARC Expert Panel Paper
Copyright © 2024 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved..
Acute decompensated heart failure (ADHF) is one of the most common reasons for hospitalizations or urgent care and is associated with poor outcomes. Therapies shown to improve outcomes are limited, however, and innovation in pharmacologic and device-based therapeutics are therefore actively being sought. Standardizing definitions for ADHF and its trajectory is complex, limiting the generalizability and translation of clinical trials to effect clinical care and policy change. The Heart Failure Collaboratory is a multistakeholder organization comprising clinical investigators, clinicians, patients, government representatives (including U.S. Food and Drug Administration and National Institutes of Health participants), payors, and industry collaborators. The following expert consensus document is the product of the Heart Failure Collaboratory convening with the Academic Research Consortium, including members from academia, the U.S. Food and Drug Administration, and industry, for the purposes of proposing standardized definitions for ADHF and highlighting important endpoint considerations to inform the design and conduct of clinical trials for drugs and devices in this clinical arena.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
JACC. Heart failure - 12(2024), 1 vom: 08. Jan., Seite 1-15 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lala, Anuradha [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Endpoints |
|---|
| Anmerkungen: |
Date Completed 08.01.2024 Date Revised 03.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jchf.2023.09.030 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365608122 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365608122 | ||
| 003 | DE-627 | ||
| 005 | 20240203231918.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jchf.2023.09.030 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1279.xml |
| 035 | |a (DE-627)NLM365608122 | ||
| 035 | |a (NLM)38069997 | ||
| 035 | |a (PII)S2213-1779(23)00696-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lala, Anuradha |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies |b HF-ARC Expert Panel Paper |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.01.2024 | ||
| 500 | |a Date Revised 03.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Acute decompensated heart failure (ADHF) is one of the most common reasons for hospitalizations or urgent care and is associated with poor outcomes. Therapies shown to improve outcomes are limited, however, and innovation in pharmacologic and device-based therapeutics are therefore actively being sought. Standardizing definitions for ADHF and its trajectory is complex, limiting the generalizability and translation of clinical trials to effect clinical care and policy change. The Heart Failure Collaboratory is a multistakeholder organization comprising clinical investigators, clinicians, patients, government representatives (including U.S. Food and Drug Administration and National Institutes of Health participants), payors, and industry collaborators. The following expert consensus document is the product of the Heart Failure Collaboratory convening with the Academic Research Consortium, including members from academia, the U.S. Food and Drug Administration, and industry, for the purposes of proposing standardized definitions for ADHF and highlighting important endpoint considerations to inform the design and conduct of clinical trials for drugs and devices in this clinical arena | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a endpoints | |
| 650 | 4 | |a heart failure | |
| 650 | 4 | |a hospitalization | |
| 650 | 4 | |a mortality | |
| 700 | 1 | |a Hamo, Carine E |e verfasserin |4 aut | |
| 700 | 1 | |a Bozkurt, Biykem |e verfasserin |4 aut | |
| 700 | 1 | |a Fiuzat, Mona |e verfasserin |4 aut | |
| 700 | 1 | |a Blumer, Vanessa |e verfasserin |4 aut | |
| 700 | 1 | |a Bukhoff, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Butler, Javed |e verfasserin |4 aut | |
| 700 | 1 | |a Costanzo, Maria Rosa |e verfasserin |4 aut | |
| 700 | 1 | |a Felker, G Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Filippatos, Gerasimos |e verfasserin |4 aut | |
| 700 | 1 | |a Konstam, Marvin A |e verfasserin |4 aut | |
| 700 | 1 | |a McMurray, John J V |e verfasserin |4 aut | |
| 700 | 1 | |a Mentz, Robert J |e verfasserin |4 aut | |
| 700 | 1 | |a Metra, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Psotka, Mitchell A |e verfasserin |4 aut | |
| 700 | 1 | |a Solomon, Scott D |e verfasserin |4 aut | |
| 700 | 1 | |a Teerlink, John |e verfasserin |4 aut | |
| 700 | 1 | |a Abraham, William T |e verfasserin |4 aut | |
| 700 | 1 | |a O'Connor, Christopher M |e verfasserin |4 aut | |
| 700 | 0 | |a HF-ARC (Heart Failure Collaboratory and Academic Research Consortium) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JACC. Heart failure |d 2013 |g 12(2024), 1 vom: 08. Jan., Seite 1-15 |w (DE-627)NLM22747550X |x 2213-1787 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2024 |g number:1 |g day:08 |g month:01 |g pages:1-15 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jchf.2023.09.030 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2024 |e 1 |b 08 |c 01 |h 1-15 | ||